Karen Madden

Karen Madden

Director/Board Member at JOHN WILEY & SONS, INC.

Net worth: - $ as of 31/05/2026

57 year
Consumer Services
Commercial Services
Health Technology

Profile

Karen N.
Madden
currently serves as Independent Director at John Wiley & Sons, Inc. since 2025.
Holds director positions at Greater Boston Chamber of Commerce, Analytical Life Science & Diagnostics Association, and The New England Council, Inc. Serves as Chief Technology Officer & Senior Vice President at EMD Millipore Corp.
and as Head-Canada Life Science Business at Merck KGaA since 2022.
Former roles include SVP-Corporate Development & External Research at VisEn Medical, Inc. and Principal at SGX Pharmaceuticals, Inc. Education includes a doctorate from Rutgers State University of New Jersey, graduate studies at the University of Pennsylvania, and undergraduate studies at Boston University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
23/04/2026 0 ( -.--% ) - $ 31/05/2026

Karen Madden active positions

CompaniesPositionStart
JOHN WILEY & SONS, INC. Director/Board Member 28/02/2025
MERCK KGAA Corporate Officer/Principal 01/01/2022
Chief Tech/Sci/R&D Officer -
Director/Board Member -
Director/Board Member -
Analytical Life Science & Diagnostics Association
Director/Board Member -

Former positions of Karen Madden

CompaniesPositionEnd
Corporate Officer/Principal 26/07/2013
Corporate Officer/Principal -
See the detail of Karen Madden's experience

Training of Karen Madden

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

79

1st degree connections

11

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies11

Commercial Services

Consumer Services

Health Technology

Health Services

Consumer Services

Consumer Services

Health Technology

Consumer Services

Commercial Services

Analytical Life Science & Diagnostics Association

Commercial Services